VALITOR
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.
VALITOR
Industry:
Biotechnology Developer Tools Medical Therapeutics
Founded:
2010-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.valitorbio.com
Total Employee:
1+
Status:
Active
Contact:
(510) 969-9246
Total Funding:
38.97 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager Google Analytics LetsEncrypt SSL By Default Global Site Tag HSTS Google Analytics 4
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
HepaTx
Hepatx is developing regenerative medicine solutions.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tilden Bio
Tilden Bio develops photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins.
Urban Mining Company
Urban Mining Company develops a proprietary Magnet-to-Magnetärecycling process.
Visgenx
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders.
Current Advisors List
Board_member
Board_member
2018-01-01
Advisor
Current Employees Featured
Steven Lo Chief Executive Officer @ Valitor
Chief Executive Officer
2022-08-01
Steve Lo Chief Executive Officer @ Valitor
Chief Executive Officer
2022-08-01
David Schaffer Co-Founder @ Valitor
Co-Founder
Wesley Jackson President & Chief Scientific Officer @ Valitor
President & Chief Scientific Officer
Kevin Healy Co-Founder @ Valitor
Co-Founder
Founder
Investors List
First Spark Ventures
First Spark Ventures investment in Series B - Valitor
ExSight Ventures
ExSight Ventures investment in Series B - Valitor
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Valitor
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series B - Valitor
Pandect Bioventures
Pandect Bioventures investment in Series B - Valitor
SVE Capital
SVE Capital investment in Series A - Valitor
Phaenomena West Capital
Phaenomena West Capital investment in Series A - Valitor
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series A - Valitor
Z-Gen Capital
Z-Gen Capital investment in Series A - Valitor
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund investment in Series A - Valitor
Official Site Inspections
http://www.valitorbio.com
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Valitor"
Leadership | VLTR-557 | AMD | Valitor
Valitor is using proven targets for ocular diseases to advance best-in-class medicines that maximize the clinical impact for patients. We have brought together seasoned biotechnology …See details»
Valitor - Crunchbase Company Profile & Funding
Contact Email info@valitorbio.com Phone Number (510) 969-9246 Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity.See details»
Leadership | VLTR-557 | AMD | Valitor - valitorbio.com
From 2015 to 2019, he was the Chief Commercial Officer at Puma Biotechnology where he built and led the worldwide commercialization and business development of the company’s first …See details»
Valitor Company Profile - Office Locations, Competitors ... - Craft
See insights on Valitor including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Valitor Information - RocketReach
Valitor is a Biotechnology Research, Business Services General, and Developer Tools company_reader located in Berkeley, California with $202000 in revenue and 17 employees. …See details»
VALITOR, INC. - VentureRadar
Website: http://www.valitorbio.com/ Develops novel macromolecular entities using multivalent polymer technology to maximize patient benefits and overcome drug design challenges, …See details»
Valitor - LinkedIn
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial control...See details»
Valitor- Engineering better medicines by leveraging its multi …
Dec 13, 2022 · Valitor is a biotech startup that uses a novel protein-biopolymer conjugation technology that was licensed from the University of California, Berkeley. Professors Kevin …See details»
Valitor - Products, Competitors, Financials, Employees, …
Valitor’s proprietary platform technology has been shown in preclinical models to safely enable intravitreal treatment with unprecedented target tissue durability and potency. For more …See details»
Valitor - Overview, News & Similar companies | ZoomInfo.com
Oct 5, 2022 · View Valitor (www.valitorbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Valitor Announces the Closing of its Series B Financing and Names ...
Oct 5, 2022 · With the company’s MVP platform, multiple copies of bioactive molecules can be combined with individual biopolymer chains to create novel macromolecular entities that are …See details»
Valitor Company Profile | Management and Employees List
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial …See details»
Valitor Bio - Berkeley Startup Cluster
Developer of new generation drugs designed to improve the current treatment strategies for a variety of diseases. The company’s drugs act within a targeted diseased tissue and modify …See details»
Press Releases | Valitor - valitorbio.com
Press Release for Valitor. Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients.See details»
Valitor Raises $28M Series B to Develop Therapy for Age ... - Bakar …
Valitor raised $28 million via a Series B led by Morningside, the 10-employee California biotech disclosed Wednesday morning.See details»
Valitor Careers, Perks + Culture | Built In
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial …See details»
04-10-23 Press Release | Valitor - valitorbio.com
Apr 10, 2023 · Valitor is conquering limitations of established drug targets by leveraging its multi-valent biopolymer technology to maximize benefits for patients. The company is engineering …See details»
Valitor | CipherBio
Explore Valitor's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
VALITOR, INC. | VentureRadar
Website: http://www.valitorbio.com/ Develops novel macromolecular entities using multivalent polymer technology to maximize patient benefits and overcome drug design ...See details»